N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state

Scrapie and related transmissible spongiform encephalopathies result in the accumulation of a protease-resistant form of an endogenous brain protein called PrP. As an approach to understanding the scrapie-associated modification of PrP, we have studied the processing and sedimentation properties of protease-resistant PrP (PrP-res) in scrapie-infected mouse neuroblastoma cells. Like brain-derived PrP-res, the neuroblastoma cell PrP-res aggregated in detergent lysates, providing evidence that the tendency to aggregate is an intrinsic property of PrP-res and not merely a secondary consequence of degenerative brain pathology. The PrP-res species had lower apparent molecular masses than the normal, protease-sensitive PrP species and were not affected by moderate treatments with proteinase K. This suggested that the PrP-res species were partially proteolyzed by the neuroblastoma cells. Immunoblot analysis of PrP-res with a panel of monospecific anti-PrP peptide sera confirmed that the PrP-res species were quantitatively truncated at the N terminus. The metabolic labeling of PrP-res in serum-free medium did not prevent the proteolysis of PrP-res, showing that the protease(s) involved was cellular rather than serum-derived. The PrP-res truncation was inhibited in intact cells by leupeptin and NH4Cl. This provided evidence that a lysosomal protease(s) was involved, and therefore, that PrP-res was translocated to lysosomes. When considered with other studies, these results imply that the conversion of PrP to the protease-resistant state occurs in the plasma membrane or along an endocytic pathway before PrP-res is exposed to endosomal and lysosomal proteases.

[1]  G. J. Raymond,et al.  The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. , 1991, The Journal of biological chemistry.

[2]  B. Caughey,et al.  Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. , 1991, Biochemistry.

[3]  B. Chesebro,et al.  Protease sensitivity and nuclease resistance of the scrapie agent propagated in vitro in neuroblastoma cells , 1991, Journal of virology.

[4]  B. Caughey.  In vitro expression and biosynthesis of prion protein. , 1991, Current topics in microbiology and immunology.

[5]  R. Race.  The scrapie agent in vitro. , 1991, Current topics in microbiology and immunology.

[6]  S. Prusiner,et al.  Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Prusiner,et al.  Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. , 1990, Biochemistry.

[8]  S. Prusiner,et al.  Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells , 1990, The Journal of cell biology.

[9]  R. Kelly.  Microtubules, membrane traffic, and cell organization , 1990, Cell.

[10]  S. Prusiner,et al.  Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells , 1990, The Journal of cell biology.

[11]  B. Chesebro,et al.  Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells , 1990, Journal of virology.

[12]  J. Hare,et al.  Mechanisms of membrane protein turnover. , 1990, Biochimica et biophysica acta.

[13]  B. Chesebro,et al.  Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells , 1989, Journal of virology.

[14]  L. Hood,et al.  Purification and properties of the cellular and scrapie hamster prion proteins. , 1988, European journal of biochemistry.

[15]  S. Prusiner,et al.  Immunoaffinity purification and neutralization of scrapie prion infectivity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  B. Chesebro,et al.  Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones , 1988, Journal of virology.

[17]  B. Chesebro,et al.  In vitro expression in eukaryotic cells of a prion protein gene cloned from scrapie-infected mouse brain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Prusiner,et al.  Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins , 1988, Journal of virology.

[19]  G. Multhaup,et al.  Molecular pathology of scrapie-associated fibril protein (PrP) in mouse brain affected by the ME7 strain of scrapie. , 1988, European Journal of Biochemistry.

[20]  S. Prusiner,et al.  Immuno-gold localization of prion filaments in scrapie-infected hamster brains. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[21]  A. Marmorstein,et al.  Isolation and structural studies of the intact scrapie agent protein. , 1987, Archives of biochemistry and biophysics.

[22]  Stanley B. Prusiner,et al.  Scrapie prion protein contains a phosphatidylinositol glycolipid , 1987, Cell.

[23]  B. Chesebro,et al.  Characterization of scrapie infection in mouse neuroblastoma cells. , 1987, The Journal of general virology.

[24]  H. Wiśniewski,et al.  Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils , 1987, Journal of virology.

[25]  T. Crow,et al.  Prion-protein immunoreactivity in human transmissible dementias. , 1986, The New England journal of medicine.

[26]  G. Multhaup,et al.  The major polypeptide of scrapie‐associated fibrils (SAF) has the same size, charge distribution and N‐terminal protein sequence as predicted for the normal brain protein (PrP). , 1986, The EMBO journal.

[27]  M. Czub,et al.  Pathogenesis of scrapie: study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associated fibrils in brains of hamsters infected intraperitoneally. , 1986, The Journal of general virology.

[28]  S. Prusiner,et al.  Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene , 1986, Cell.

[29]  P. Brown,et al.  Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. , 1986, The New England journal of medicine.

[30]  H. Cho,et al.  Antibody to scrapie-associated fibril protein identifies a cellular antigen. , 1986, The Journal of general virology.

[31]  H. Diringer,et al.  Scrapie: concept of a virus‐induced amyloidosis of the brain. , 1985, The EMBO journal.

[32]  L. Manuelidis,et al.  Specific proteins associated with Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Chesebro,et al.  Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain , 1985, Nature.

[34]  M. Braunfeld,et al.  Identification of prion amyloid filaments in scrapie-infected brain , 1985, Cell.

[35]  Ruedi Aebersold,et al.  A cellular gene encodes scrapie PrP 27-30 protein , 1985, Cell.

[36]  S. Prusiner,et al.  Scrapie PrP 27-30 is a sialoglycoprotein , 1985, Journal of virology.

[37]  J. Hare,et al.  Degradation of surface-labeled hepatoma membrane polypeptides: effect of inhibitors. , 1984, Archives of biochemistry and biophysics.

[38]  S. Prusiner,et al.  Antibodies to a scrapie prion protein , 1984, Nature.

[39]  S. Prusiner,et al.  Scrapie prions aggregate to form amyloid-like birefringent rods , 1983, Cell.

[40]  H. Gelderblom,et al.  Scrapie infectivity, fibrils and low molecular weight protein , 1983, Nature.

[41]  H. Wiśniewski,et al.  Scrapie-associated fibrils in Creutzfeldt–Jakob disease , 1983, Nature.

[42]  S. Prusiner,et al.  A protease-resistant protein is a structural component of the Scrapie prion , 1983, Cell.

[43]  D. Simon,et al.  Towards purification of the scrapie agent. , 1983, European journal of biochemistry.

[44]  S. Froehner,et al.  Degradation of acetylcholine receptors in muscle cells: effect of leupeptin on turnover rate, intracellular pool sizes, and receptor properties , 1983, The Journal of cell biology.

[45]  P. Seglen.  Inhibitors of lysosomal function. , 1983, Methods in enzymology.

[46]  S. Prusiner,et al.  Identification of a protein that purifies with the scrapie prion. , 1982, Science.

[47]  S. Prusiner.  Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[48]  P. Libby,et al.  Degradation of the acetylcholine receptor in cultured muscle cells: Selective inhibitors and the fate of undegraded receptors , 1980, Cell.

[49]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[50]  P. Seglen,et al.  Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin. , 1979, European journal of biochemistry.

[51]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[52]  W. Gratzer,et al.  Formation and structure of gels and fibrils from glucagon. , 1969, European journal of biochemistry.

[53]  J. Griffith,et al.  Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.

[54]  TIKVAH ALPER,et al.  Does the Agent of Scrapie Replicate without Nucleic Acid ? , 1967, Nature.

[55]  I. Pattison,et al.  The possible nature of the transmissible agent of scrapie , 1967, Veterinary Record.

[56]  J. Griffith,et al.  Self-replication and scrapie. , 1967, Nature.